日本語 
ZEAL, a DX company inside the Avant Group has introduced “MEDSCOPE,” a data integration and analytics environment created for the OTC pharmaceutical industry. The service starts with OTC drug manufacturers. Is meant to help businesses connect scattered data for better supply and marketing choices.
MEDSCOPE connects sales performance, in-store details, consumer trends and outside data such as weather and disease patterns. It provides analysis on topics that matter most to the industry. Can be adjusted to fit each company’s unique needs.
A key feature of MEDSCOPE is its ability to pull together data from stores and business partners including Excel and CSV files. This reduces the amount of work required to collect and clean data. The platform also combines point-of-sale data with information about shelf placement and in-store activities. This helps companies understand promotions and shifts, in demand clearly.
Also Read: SOLA Biosciences Japan Secures ¥6B Grant for ALS Gene Therapy
The release shows how more and more companies in consumer healthcare are relying on data to make decisions. OTC manufacturers deal with changing demand, seasonal changes and new ways that people behave which makes looking at data, from areas more and more important.
ZEAL wants to take MEDSCOPE beyond OTC drug manufacturers and offer it to consumer goods companies that mostly sell through drugstores.
English